StockData
Nexentis Technologies Inc. logo

Nexentis Technologies Inc. (NXTS) stock

NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$1.82−0.17 (-8.42%)

Close on Nov 17, 2026Market cap $2.65MP/E –Yield –

Nexentis Technologies profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Nexentis Technologies's profit margin for the twelve months ending Sep 30, 2025 was -3179.9%. For fiscal 2024 it was -2472.9%, against -2479.8% the year before. The highest annual figure on record is -83.7% in fiscal 2018.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-2472.9%+7.0
FY2023Dec 31, 2023-2479.8%−1023.1
FY2022Dec 31, 2022-1456.7%−356.5
FY2021Dec 31, 2021-1100.2%−414.3
FY2020Dec 31, 2020-685.9%+435.4
FY2019Dec 31, 2019-1121.3%−1037.6
FY2018Dec 31, 2018-83.7%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2025Sep 30, 202521450.0%+26079.4
Q1 FY2025Mar 31, 2025-1807.6%−59.8
Q4 FY2024Dec 31, 2024-973.8%+670.9
Q3 FY2024Sep 30, 2024-25155.6%−23217.4
Q2 FY2024Jun 30, 2024-4629.4%−3213.3
Q1 FY2024Mar 31, 2024-1747.7%−1125.7
Q4 FY2023Dec 31, 2023-1644.7%+1789.4
Q2 FY2023Jun 30, 2023-1938.1%+2105.2
Q1 FY2023Mar 31, 2023-1416.1%+101.3
Q4 FY2022Dec 31, 2022-622.0%+201.9
Q3 FY2022Sep 30, 2022-3434.1%−1630.6
Q2 FY2022Jun 30, 2022-4043.3%−1320.3
Q1 FY2022Mar 31, 2022-1517.5%−1117.4
Q4 FY2021Dec 31, 2021-823.9%−695.5
Q3 FY2021Sep 30, 2021-1803.6%−1228.3
Q2 FY2021Jun 30, 2021-2723.1%−1499.4
Q1 FY2021Mar 31, 2021-400.1%−125.9
Q4 FY2020Dec 31, 2020-128.4%–
Q1 FY2020Mar 31, 2020-575.2%–
Q4 FY2019Dec 31, 2019-1223.7%–
Q1 FY2019Mar 31, 2019-274.2%–

More Nexentis Technologies figures

See a number that looks wrong?